Actively Recruiting
Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
Led by European Institute of Oncology · Updated on 2026-01-08
25
Participants Needed
1
Research Sites
106 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
investigate the molecular differences between primitive lung cancer and the metastatic site.
CONDITIONS
Official Title
Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older who are fit enough to tolerate surgery
- Low operative risk based on respiratory and cardiac assessment
- Patient has clearly expressed willingness to participate
- Availability of tumor tissue for DNA extraction and next-generation sequencing
You will not qualify if you...
- Women of childbearing age who are pregnant, breastfeeding, or planning pregnancy during the study
- Any illness, metabolic disorder, physical exam, or lab finding that contraindicates participation
- Recent or ongoing severe or clinically significant infection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Istituto Europeo di Oncologia
Milan, Italy
Actively Recruiting
Research Team
L
Luca Bertolaccini
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here